Article by Andrew Jack in Financial Times (15 December 2009)
Nine western pharmaceutical companies face fresh pressure to ease control over their HIV medicines following the establishment of an international mechanism designed to increase treatment access in the developing world.
The board of Unitaid, the French-backed health funding agency, voted on Tuesday to create a “patent pool” [...]
UNITAID EXECUTIVE BOARD APPROVES BREAKTHROUGH PLAN TO MAKE AIDS TREATMENT MORE WIDELY AVAILABLE AT LOWER COST
PATENT POOL COULD SAVE OVER ONE BILLION DOLLARS A YEAR
Geneva, 14 December 2009 — Today UNITAID’s Executive Board made a landmark decision to establish a Patent Pool for AIDS medicines. The pool, scheduled to start operating in mid-2010, aims to [...]
STATEMENT ON PATENT POOL SCOPE BY UNITAID CHAIR
PHILIPPE DOUSTE-BLAZY
To fulfil its mission of scaling up access to medicines in developing countries, UNITAID has elaborated an implementation plan for an HIV/AIDS medicines patent pool. That plan will be discussed for approval at UNITAID’s Executive Board meeting next week, on 14 December. In developing the plan, [...]
Early Day Motion
EDM 1553
HIV TREATMENTS AND CHILDREN
01.06.2009
Borrow, David S
That this House notes with concern that globally most children who need treatment for HIV are not receiving it; further notes that there is a lack of appropriate HIV treatments for children and that the number of adults who have become resistant to basic HIV treatment and [...]
Philippe Douste-Blazy, Président d’UNITAID et Secrétaire Général Adjoint des Nations-Unies, a publié une lettre, le 18 avril, dans le journal de santé britannique The Lancet, pour inviter la compagnie pharmaceutique GlaxoSmithKline à se joindre à la communauté de brevets d’UNITAID dédiée aux médicaments contre le SIDA dans les pays en développement.
La lettre est en réponse [...]
